Get the Stockscreener App
0.491
4.10%
-0.021
20 20 Biolabs Inc stock is traded at $0.491, with a volume of 81,479.
It is down -4.10% in the last 24 hours and down -13.40% over the past month.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
See More
Previous Close:
$0.512
Open:
$0.5056
24h Volume:
81,479
Relative Volume:
0.12
Market Cap:
$6.02M
Revenue:
$1.85M
Net Income/Loss:
$-5.56M
P/E Ratio:
-0.6475
EPS:
-0.7583
Net Cash Flow:
-
1W Performance:
-5.14%
1M Performance:
-13.40%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.491
$0.5056
1-Week Range:
$0.491
$0.5652
52-Week Range:
$0.491
$14.09
20 20 Biolabs Inc Stock (AIDX) Company Profile
Name
20 20 Biolabs Inc
Sector
Industry
Phone
(240) 453-6339
Address
9430 KEY WEST AVENUE, ROCKVILLE
Compare AIDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIDX
20 20 Biolabs Inc
|
0.491 | 6.02M | 1.85M | -5.56M | 0 | -0.7583 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
20 20 Biolabs Inc Stock (AIDX) Latest News
Rokit Healthcare, US 20/20 BioLabs to Co-Develop AI Multi-Cancer Prediction Platform - Seoul Economic Daily
20/20 Biolabs, Inc. (AIDX) stock price, news, quote and history - Yahoo Finance UK
20/20 BioLabs enters standstill pact on preferred stock - Investing.com
20/20 BioLabs Enters Temporary Standstill Agreement Limiting Series E Preferred Stock Conversions - Quiver Quantitative
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock - The Manila Times
Streeterville Can Convert 20/20 BioLabs Stock Only 10% Above Minimum Price - Stock Titan
20/20 Biolabs, Inc. Signs Standstill Agreement With Streeterville Capital – SEC 8-K Filing Details (July 2026) - Minichart
20/20 Biolabs Received Notice of Noncompliance - TradingView
20/20 Biolabs (Nasdaq: AIDX) signs standstill as Nasdaq flags bid-price issue - Stock Titan
Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
What Factors Led to 20/20 Biolabs' Dramatic Stock Collapse - Kavout | AI
20/20 BioLabs reports Q2 MCED revenue to be highest to date - Investing.com
20/20 BioLabs highlights OneTest™ strategy for Medicare coverage and reports strong Q2 revenue growth - Pluang
20/20 BioLabs Highlights Investor Webinar Focused on - GlobeNewswire
Virax Biolabs | 20-F: Registration statement / Annual report / Transition report - Moomoo
AIDX SEC Filings20/20 Biolabs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
20/20 Biolabs (AIDX) Jumps Nearly 5% as Stock Approaches Key $0.67 ResistanceIchimoku Cloud - dars.gov.et
20/20 Biolabs to present OneTest webinar outlining Medicare pathway, modeling and reimbursement plan - TradingView
OneTest growth vision: 20/20 Biolabs (AIDX) targets Medicare MCED market - Stock Titan
20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics' 40,000+ U.S. Practitioners - The National Law Review
20/20 Biolabs Inc. (AIDX) Edges Higher in Low-Price Territory as Support HoldsWyckoff Spring - dars.gov.et
20/20 Biolabs, Inc. Actuals & Estimates (NASDAQ:AIDX) - TradingView
Price to sales forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to book forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to earnings forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
AIDX | 20/20 Biolabs, Inc. Common Executive Compensation - Quiver Quantitative
Large share authorization and new equity plan up for 20/20 Biolabs (AIDX) vote - Stock Titan
20/20 BioLabs Bets on Radical Transparency with Monthly Investor Calls - BriefGlance
20/20 BioLabs Launches Monthly Investor Webinar Series to Enhance Shareholder Communication - Quiver Quantitative
20/20 BioLabs starts monthly webinars, with a OneTest discount for attendees - Stock Titan
20/20 Biolabs, Inc.(NasdaqCM: AIDX) added to S&P TMI Index - marketscreener.com
AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Meet Greater Washington's newest publicly traded companiesWashington Business Journal - The Business Journals
AIDX - Finviz
20/20 Biolabs Inc. (AIDX) Surges 13.6%: Breaking Out on Heavy VolumeSign of Strength - dars.gov.et
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gapping stocks in Monday's session - ChartMill
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Trending Stocks Today | Aspire Biopharma up 6.03% Post-Market - Moomoo
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
20/20 Biolabs (AIDX) Surges 10.86%: Key Levels and Market SentimentETF AUM Growth - newsline.com
20/20 Biolabs (AIDX) Dips 7.75% – Key Support Test in FocusFactor Crowding - newsline.com
20/20 Biolabs (AIDX) Slumps 7.75% as Stock Nears Key $0.76 Support LevelFactor Rotation - newsline.com
Director Kathryn Gregory exits Longevity Health Holdings (XAGE) board without dispute - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
20/20 Biolabs (NASDAQ: AIDX) asks shareholders to raise authorized shares to 500M - Stock Titan
20/20 Biolabs, Inc. Files Form 8-K Announcing Amended and Restated Bylaws and Nasdaq Listing as Emerging Growth Company - Minichart
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters - The Manila Times
20/20 Biolabs' OneTest™ Selected for Vermont Firefighter Cancer Screening Initiative, Expected to Generate $500,000 in Revenue - Quiver Quantitative
20/20 Biolabs, Inc.Common Stock (Nasdaq:AIDX) Stock Quote - The Chronicle-Journal
20 20 Biolabs Inc Stock (AIDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):